Dr. Eckhert is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-6661
Education & Training
University of California San Francisco School of MedicineClass of 2017
Certifications & Licensure
CA State Medical License 2018 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 35 citationsOrgan responses with daratumumab therapy in previously treated AL amyloidosis.Alfred Chung, Gregory P. Kaufman, Surbhi Sidana, Erik Eckhert, Stanley L. Schrier
Blood Advances. 2020-02-11 - 8 citationsGrading cardiac response in AL amyloidosis: implications for relapse and survivalErik Eckhert, Ronald M. Witteles, Gregory P. Kaufman, Richard A. Lafayette, Sally Arai
British Journal of Haematology. 2019-07-01 - 17 citationsBreast Cancer Diagnosis, Treatment, and Outcomes of Patients From Sex and Gender Minority Groups.Erik Eckhert, Olivia Lansinger, Victor Ritter, Mina Liu, Summer Han
JAMA Oncology. 2023-04-01
Abstracts/Posters
- Favorable Long-Term Outcomes after Daratumumab Discontinuation in AL Amyloidosis Patients Achieving Deep ResponsesErik Eckhert, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Long-Term Outcomes and Organ Responses with Daratumumab Therapy in Previously Treated Patients with AL AmyloidosisErik Eckhert, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
